EFFECT OF A SUSTAINED-RELEASE FORMULATION OF DILTIAZEM ON THE DEVELOPMENT OF ATHEROSCLEROSIS IN CHOLESTEROL-FED RABBITS

被引：25

作者：

DICCIANNI, MB

CARDIN, AD

BRITT, AL

JACKSON, RL

SCHWARTZ, A

机构：

[1] UNIV CINCINNATI,COLL MED,DEPT PHARMACOL & CELL BIOPHYS,CINCINNATI,OH 45267

[2] UNIV CINCINNATI,COLL MED,DIV LAB ANIM MED,CINCINNATI,OH 45267

来源：

ATHEROSCLEROSIS | 1987年 / 65卷 / 03期

关键词：

D O I：

10.1016/0021-9150(87)90035-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：199 / 205

页数：7

共 28 条

[11]

Hicks C.R., 1982, FUNDAMENTAL CONCEPTS

[12] SUPPRESSION OF EXPERIMENTAL ATHEROSCLEROSIS BY THE CA++-ANTAGONIST LANTHANUM - POSSIBLE ROLE OF CALCIUM IN ATHEROGENESIS [J].

KRAMSCH, DM ;

ASPEN, AJ ;

APSTEIN, CS .

JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (05) :967-981

[13]

MCCALL D, 1985, CURR PROBL CARDIOL, V10, P38

[14]

NAGAO E, 1982, J MOL CELL CARDIOL, V12, P29

[15] INEFFECTIVENESS OF CA-2+-ANTAGONISTS NICARDIPINE AND DILTIAZEM ON EXPERIMENTAL ATHEROSCLEROSIS IN CHOLESTEROL-FED RABBITS [J].

NAITO, M ;

KUZUYA, F ;

ASAI, K ;

SHIBATA, K ;

YOSHIMINE, N .

ATHEROSCLEROSIS, 1984, 51 (2-3) :343-344

[16] PHARMACOKINETICS OF DILTIAZEM IN SELECTED ANIMAL SPECIES AND HUMAN-BEINGS [J].

PIEPHO, RW ;

BLOEDOW, DC ;

LACZ, JP ;

RUNSER, DJ ;

DIMMIT, DC ;

BROWNE, RK .

AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (03) :525-528

[17]

ROBERTS R, 1986, J AM COLL CARDIOL, V7, pA68

[18] VERAPAMIL SUPPRESSES ATHEROSCLEROSIS IN CHOLESTEROL-FED RABBITS [J].

ROULEAU, JL ;

PARMLEY, WW ;

STEVENS, J ;

WIKMANCOFFELT, J ;

SIEVERS, R ;

MAHLEY, RW ;

HAVEL, RJ ;

BRECHT, W .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 1 (06) :1453-1460

[19] PHARMACOLOGY OF CALCIUM-ANTAGONISTS [J].

SCHWARTZ, A ;

MATLIB, MA ;

BALWIERCZAK, J ;

LATHROP, DA .

AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (07) :C3-C7

[20] CELLULAR ACTION OF CALCIUM-CHANNEL BLOCKING-DRUGS [J].

SCHWARTZ, A ;

TRIGGLE, DJ .

ANNUAL REVIEW OF MEDICINE, 1984, 35 :325-339

← 1 2 3 →